Incretin-based therapy and the risk of diabetic foot ulcers and related events.

Nikki C C WerkmanJohanna H M DriessenOlaf H KlungelNicolaas S SchaperPatrick C SouvereinCoen D A Stehouwer Johannes T H Nielen

Published in: Diabetes, obesity & metabolism (2024)

Incretin-based therapy was associated with a lower risk of DFU and DFU-related outcomes. This suggests benefits for the use of this treatment in people at risk of DFU.

Keyphrases

stem cells
metabolic syndrome
cell therapy
replacement therapy
bone marrow
drug induced
weight loss
wound healing